Skip to main content

Table 2 Gradient program

From: Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detector

Time in min % mobile phase A % mobile phase B
0.1 75 25
10.0 70 30
45.0 40 60
55.0 40 60
55.01 75 25
65.0 75 25